Global Player BioTechUSA Invests HUF 1 Billion to Improve Capacity

With an investment of HUF 1 billion (1 EUR= 386 HUF) – of which HUF 245.4 million is state aid – the BioTechUSA group (dietary supplement manufacturer) has expanded its manufacturing and logistics center with an automated package-assortment warehouse, the company announced at a press conference in Szada (near Budapest).

Bálint Lévai, CEO and co-owner of BioTechUSA, a purely Hungarian-owned group of companies, said that they are constantly improving, which is reflected not only in product development and business strategy, but also in the efficiency of service. “With our new automated warehouse we can deliver parcels to our customers faster and with fewer errors,” he added.

Diána Markovics, managing director of BioTechUSA responsible for supply areas, stressed that the investment included the installation of a 450 square meter, two-story automated warehouse and a four-story social block on more than 1,000 square meters to increase employee retention. She added that

the modernized complex in Szada employs almost 600 workers on a two-shift basis.

The managing director in charge of the supply areas pointed out that the size of the changing rooms and the dining area in the logistics area has been significantly increased for the convenience of the workers. In addition, a two-story gym has been built in the new building, she mentioned.

The Hungarian-owned BioTechUSA group is present in more than 103 countries with 48 webshops, 307 franchise stores, 1,800 employees, and 4,500 partners, with a current product range of more than 2,000 products.

In 2023, the group’s total turnover exceeded HUF 90 billion.

According to its own announcement, the BioTechUSA group ended the 2022 financial year with total revenues of HUF 82.336 billion, EBITDA (earnings before interest, taxes, depreciation, and amortization) of HUF 11.5 billion and a profit after tax of HUF 6.298 billion.

Via MTI; Featured image via Facebook/BioTechUSA